11C-labeling of busulphan

This publication has 16 references indexed in Scilit:

• PET studies of potential chemotherapeutic agents—X. Synthesis of “no-carrier-added” (11C)-HECNU: The hydroxyethyl analog of the chemotherapeutic agent BCNU
  International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1991
• Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia [see comments]
  Blood, 1989
• Direct incorporation of [¹¹C]carbon dioxide for labeling bioactive molecules. An application to [¹¹C] labeled tamoxifen
  Journal of Labelled Compounds and Radiopharmaceuticals, 1989
• Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia
  Blood, 1989
• Pharmacokinetic and metabolic studies of busulfan in rat plasma and brain
  European Journal of Drug Metabolism and Pharmacokinetics, 1988
• CONVULSIONS DUE TO HIGH-DOSE BUSULPHAN
  The Lancet, 1984
• Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide
  New England Journal of Medicine, 1983
• Chemical Considerations in the Accelerator Production of N-13: N-13-Nitrosourea Preparation
  IEEE Transactions on Nuclear Science, 1979
• The production of ultra high activity 11C-labeled hydrogen cyanide, carbon dioxide, carbon monoxide and methane via the reaction (XV)
  The International Journal of Applied Radiation and Isotopes, 1975
• The Chemistry of Cytotoxic Alkylating Agents
  Advances in Cancer Research, 1953